Clinical TrialsSearch results
Number of results: 759
Other
- Study on Prevention of Gastric Cancer by Early Detection of Helicobacter pylori Infection and Its Eradication(2nd-Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health and Welfare of Japan)
- Gastritis
- Second-Term Comprehensive 10-Years Strategy for Cancer Control (Ministry of Health and Welfare of Japan):Cancer Prevention
- 2007-01-31
Not yet recruiting
- Collaborative Trial of Fluvastatin on Atrial Fibrillation
- paroxysmal atrial fibrillation or transient atrial fibrillation
- CO-FAT study group
- 2007-01-31
Other
- The efficacy and the safety of gemcitabine / S-1 combination therapy in patients with advanced non-resectable or post-operative recurrent biliary tract cancer -multicenter phase II study
- Non-resectable or post-operative recurrent biliary tract cancer
- Faculty of Medicine, University of Tokyo
- 2007-02-01
Other
- MIRACLE-ICD outcome measured in Japanese indication
- Congestive Heart Failure, Ventricular Tachyarrhythmia.
- Medtronic Japan, Co., Ltd.
- 2007-02-01
Recruiting
- An investigational study of chemoradiosensitivity prediction with genetic profiling of esophageal biopsy for squamous cell carcinoma of the esophagus
- Esophageal cancer
- University of Toyama
- 2007-02-01
Other
- Clinical study of pranlukast as early seasonal treatment for Japanese cedar pollinosis
- Japanese cedar pollinosis
- Group study of Early Intervention of Pollinosis with Pranlukast
- 2007-02-05
Other
- Aldose Reductase Inhibitor-Diabetes Complications Trial (ADCT)
- Diabetic peripheral neuropathy
- The Aldose Reductase Inhibitor-Diabetes Complications Trial (ADCT) Study Group
- 2007-02-20
Other
- The six months study of unoprostone eye drop therapy for retinitis pigmentosa
- Retinitis Pigmentosa
- Ophthalmology
- 2007-03-01
Other
- Clinical examination about immunoadsorption therapy for dilated cardiomyopathy
- dilated cardiomyopathy
- Department of Cardiology, Kitasato Institute Hospital
- 2007-03-01
Other
- Clinical study of a combined use of Gefitinib and autologous lymphocyte-activated killer cells (LAK) therapy for advanced non-small cell lung cancer.
- non-small cell lung cancer
- Juntendo University, School of Medicine
- 2007-03-16